InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and Medical Officer
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nov 18, 2019--
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nov 18, 2019--